Surgery Partners Provides Update on 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Surgery Partners (SGRY) PT Lowered to $13 at Jefferies Following 3Q
November 1, 2017 8:21 AM EDTJefferies lowered its price target on Surgery Partners (NASDAQ: SGRY) to $13.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report. Unlike many HC services peers, SGRY managed in Q3 to beat on top-line ($330MM vs $302MM consensus) and deliver inline EBITDA... More



